In Utero Origins of Acute Leukemia in Children

Adam J de Smith1,2, Logan G Spector3

  • 1Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.

Biomedicines
|January 26, 2024
PubMed

Insights

Childhood acute leukemias, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), may originate before birth. Research explores prenatal risk factors and evidence for in utero leukemogenesis.

Area of Science:

  • Hematology
  • Pediatric Oncology
  • Cancer Epidemiology

Background:

  • Acute leukemias, primarily ALL and AML, are significant hematologic cancers.
  • The early onset of childhood ALL suggests a potential in utero origin.
  • Prenatal risk factors for pediatric acute leukemias have been extensively studied.

Purpose of the Study:

  • To review the evidence supporting an in utero origin for childhood acute leukemias.
  • To examine findings from twin studies and backtracking studies on prenatal leukemogenesis.
  • To synthesize the literature on gestation as a critical window for leukemia risk.

Main Methods:

  • Narrative review of existing scientific literature.
  • Analysis of circumstantial and direct evidence for prenatal leukemogenesis.
  • Examination of studies investigating twin concordance and molecular backtracking.

Main Results:

  • Circumstantial evidence supports the hypothesis of in utero origin.
  • Direct evidence from specific studies provides further support.
  • Gestation is identified as a critical period for leukemia development.

Conclusions:

  • The evidence strongly suggests that childhood acute leukemias can originate during gestation.
  • Further research into prenatal factors is crucial for understanding and preventing childhood leukemia.
  • Prenatal leukemogenesis is a key area for future investigation in pediatric hematology.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
331
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.0K
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
955
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
309
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
3.0K